Results 261 to 270 of about 273,871 (338)

YWHAG promotes the progression of lung adenocarcinoma through the JAK2/STAT3 pathway. [PDF]

open access: yesCancer Cell Int
Zheng H   +7 more
europepmc   +1 more source

Lung Adenocarcinoma and Peripheral Blood Eosinophilia. [PDF]

open access: yesCureus
Pereira MI   +4 more
europepmc   +1 more source

The transcription factor TSHZ3 promotes tumor immunosuppression and inhibits metastasis in lung adenocarcinoma. [PDF]

open access: yesFront Immunol
Zhang X   +10 more
europepmc   +1 more source

Low RYR2 Level Relates to Poor Prognosis of Patients With Lung Adenocarcinoma by Promoting Tumor Cell Proliferation and Inhibiting Immune Cell Infiltration

open access: yesBiotechnology and Applied Biochemistry, EarlyView.
ABSTRACT Ryanodine receptor type 2 (RYR2) is a large calcium channel that has been identified as one of the most frequently mutated genes in lung adenocarcinoma (LUAD). Despite its potential significance, the role of RYR2 in LUAD remains poorly understood.
Tao Wang   +3 more
wiley   +1 more source

Adenocarcinoma lung in a painter

open access: yesJournal of Cancer Research and Therapeutics, 2011
Kumar, Arinaganhalli Subbanna. Praveen   +3 more
openaire   +2 more sources

GDF10 Regulates Iron‐Dependent Lipid Oxidation in Colorectal Cancer Cells Through Interaction With IGF2

open access: yesBiotechnology and Applied Biochemistry, EarlyView.
ABSTRACT Background: This study aims to identify genes with a high likelihood of genetic variation, significant expression differences, and prognostic implications in colorectal cancer (CRC) patients. The research also seeks to investigate the role and mechanisms of key genes in CRC through the analysis of health information data and a combination of ...
Kaobin Ouyang   +3 more
wiley   +1 more source

A METTL3-NFE2L3 axis mediates tumor stemness and progression in lung adenocarcinoma. [PDF]

open access: yesSci Adv
Zhao Y   +11 more
europepmc   +1 more source

Effect of hydration schedules on dose‐limiting toxicity in patients with head and neck squamous cell carcinoma treated with cisplatin

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aims The aim of this study was to determine if head and neck squamous cell carcinoma (HNSCC) patients treated with cisplatin chemoradiotherapy and short hydration (SH) experience less dose‐limiting toxicity (DLT) and receive more cisplatin than those with medium hydration (MH) or long hydration (LH).
Anouk W. M. A. Schaeffers   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy